BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10819304)

  • 1. Anticancer and some biological activities of thiazinotrienomycin B.
    Hosokawa N; Iinuma H; Takeuchi T; Sato S; Yamori T; Tsuchiya KS; Hori M
    J Antibiot (Tokyo); 2000 Mar; 53(3):306-8. PubMed ID: 10819304
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic evaluation of response to treatment of human tumors grown in the nude mouse.
    Kyriazis AA; Kyriazis AP; Kereiakes JG; Soloway MS; McCombs WB
    Exp Cell Biol; 1983; 51(2):83-95. PubMed ID: 6840388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of quinocarmycin citrate (KW-2152) against human tumor xenografts serially transplanted into nude mice.
    Inoue S; Kubota T; Ohishi T; Kuzuoka M; Oka S; Shimoyama Y; Kikuyama S; Ishibiki K; Abe O
    Keio J Med; 1988 Dec; 37(4):355-64. PubMed ID: 3226024
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Halmos G
    Int J Oncol; 2002 Feb; 20(2):397-402. PubMed ID: 11788908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.
    Arap W; Pasqualini R; Ruoslahti E
    Science; 1998 Jan; 279(5349):377-80. PubMed ID: 9430587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-, energy-metabolism and cell proliferation in tumors.
    Streffer C
    Adv Exp Med Biol; 1994; 345():327-33. PubMed ID: 8079725
    [No Abstract]   [Full Text] [Related]  

  • 9. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo.
    Tressler RJ; Garvin LJ; Slate DL
    Int J Cancer; 1994 May; 57(4):568-73. PubMed ID: 8181860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vivo and in vitro antitumor activities of Aclacinomycin A made in China].
    Yang JL; Han JX; Shen ZM; Lu LJ; Xu CH; Zhang HL; Wang DE; Xu SH
    Yao Xue Xue Bao; 1988 May; 23(5):321-6. PubMed ID: 3213510
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies of the antitumor effect of TNP-470 on malignant brain tumors. Antitumor effect of TNP-470 on a human medulloblastoma xenograft line.
    Isobe N; Uozumi T; Kurisu K; Kawamoto K
    Neuropediatrics; 1996 Jun; 27(3):136-42. PubMed ID: 8837073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental antitumor activity of Navelbine.
    Cros S; Wright M; Morimoto M; Lataste H; Couzinier JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):15-20. PubMed ID: 2711203
    [No Abstract]   [Full Text] [Related]  

  • 14. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
    Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug sensitivity of rat bladder cancer in syngeneic hosts and athymic nude mice.
    Kitagawa H; Nakamura M; Kiuchi Y; Iwaguchi T
    Gan; 1981 Oct; 72(5):802-5. PubMed ID: 7327381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y; Weisz B; Gana-Weisz M; Ben-Baruch G; Kloog Y
    Int J Cancer; 1999 Mar; 80(6):911-8. PubMed ID: 10074926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
    Matsumoto K; Konno H; Tanaka T; Baba M; Kanai T; Kamiya K; Ohba K; Nakamura S
    Jpn J Cancer Res; 2000 Jul; 91(7):748-52. PubMed ID: 10920283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing beta-(5',6',7'-trimethoxy-2'-indolyl)acryloyl group.
    Amishiro N; Nagamura S; Kobayashi E; Okamoto A; Gomi K; Okabe M; Saito H
    Bioorg Med Chem; 2000 Jul; 8(7):1637-43. PubMed ID: 10976511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of anticancer agents, growth and chemosensitivity of human tumour xenografts in a segregating stock of AF nude mice.
    Maruo K; Emura R; Ohnishi Y; Endo S; Ueyama Y; Nomura T
    Lab Anim; 1991 Oct; 25(4):342-7. PubMed ID: 1753695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neoplastic growth by N-homocysteine thiolactonyl retinamido cobalamin.
    McCully KS; Tzanakakis GN; Vezeridis MP
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):117-22. PubMed ID: 2616893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.